ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Tango Therapeutics, Inc. (TNGX)

Nasdaq · Common stock · Pharmaceutical Preparations

$27.93+0.95 (+3.52%)

As of Oct 22, 4:00 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow TNGX in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on TNGX and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free TNGX chart →

TNGX at a glance

Key statistics

$4.71B

Market capitalization

Previous close
$26.98
Open
$26.67
Day range
$25.94 – $27.98
Volume
5.96M
Average volume (30 sessions)
3.69M
Shares outstanding
168.61M
Earnings per share
$(0.73)
Price / book
4.6
Price / sales
87.5
Beta (1 year, vs SPY)
1.31

Where the price sits in its year

52-week range

77% of the range

Below the 52-week high
-18.8%
Above the 52-week low
+317.5%

Completed sessions through Oct 22, 2026

Technical snapshot

Above its 50-day and 200-day averages

20-day average
$23.82+17.2%
50-day average
$23.90+16.9%
200-day average
$21.99+27.0%
RSI (14)66.4

Between the conventional 30 and 70 bands.

+23.0%

1 week

+14.2%

1 month

+4.9%

3 months

+215.2%

Year to date

+210.7%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with TNGX

Every plan

TNGX on Pro Charting

Every intraday interval in real time, the drawing kit and the full set of technical studies on TNGX.

See the plans →

Every plan

Screen names like TNGX

The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.

See the plans →

Analysis Tools Only

Set a price line on TNGX

Put TNGX on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.

See the plans →

Stock Alerts + Tools

Open alerts on TNGX

See whether there is an open premium alert on TNGX, with its entry, stop and exit, each one reviewed by an analyst before it is sent.

See the plans →

From the public news wire

TNGX headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →

  • Crystal Adam

    −27.0K

    President, R&D · Option exercise

    · Oct 1, 2026

  • Crystal Adam

    −600

    President, R&D · Open-market sale

    $15.19K · Oct 1, 2026

  • Crystal Adam

    +27.0K

    President, R&D · Option exercise

    $140.40K · Oct 1, 2026

  • Crystal Adam

    −26.4K

    President, R&D · Open-market sale

    $645.60K · Oct 1, 2026

  • Newcomb Jessica

    −700

    Principal Accounting Officer · Open-market sale

    $15.96K · Sep 22, 2026

  • Newcomb Jessica

    −2.4K

    Principal Accounting Officer · Open-market sale

    $60.41K · Sep 22, 2026

  • Newcomb Jessica

    −5.1K

    Principal Accounting Officer · Open-market sale

    $122.24K · Sep 22, 2026

  • Crystal Adam

    +27.0K

    President, R&D · Option exercise

    $140.40K · Sep 1, 2026

About Tango Therapeutics, Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
Boston, MA
Employees
137
Listed since
Aug 11, 2021
Website
tangotx.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.